Benzydamine in Sore Throat Pain Relief (BePaiR Study) (BePaiR)
Phase IV Study Comparing the Efficacy and Safety of Benzydamine Hydrochloride 0,3% Oromucosal Spray and Benzydamine Hydrochloride 3 mg Lozenges in Patients With Acute Sore Throat
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A
A PHASE4 clinical study on Acute Sore Throat, this trial is completed. The trial is conducted by Aziende Chimiche Riunite Angelini Francesco S.p.A and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Zak-Pharma Dienstleistung Ges.m.b.H.
For direct contact, visit the study record on ClinicalTrials.gov .